Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Jun 30, 2010


Sirius Genomics this week announced that Kamran Alam has been appointed senior director of business development.

Alam brings to Sirius 12 of years experience in the biotech and medical device industry. Before joining Sirius Genomics, Alam held positions at the Center for Drug Research and Development, Angiotech Pharmaceuticals, and AnorMED, where his work focused on executing partnering deals, mergers, acquisitions, and licensing transactions.

"Sirius Genomics is on track with our existing products and looking to grow our pipeline," Chris Wagner, CEO of Sirius Genomics, said in a statement announcing Alam's appointment. Alam's "extensive background in partnering with both global pharmaceutical and medical device companies, as well as experience in building collaborations with academic and translational research centers, will support our commercialization initiatives and product pipeline development."

Stan Lapidus is the founder, president, and CEO of SynapDx, a new company developing diagnostic tests for the early detection of autism. He is a co-founder of Helicos BioSciences, Cytyc, and Exact Sciences.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.